Hims & Hers COO awarded 365,058 PRSU shares

Hims & Hers Health, Inc. Chief Operating Officer Michael Chi reported acquiring 365,058 shares of Class A common stock through earned performance-based restricted stock units (PRSUs).

Rhea-AI Filing Summary

Hims & Hers Health, Inc. Chief Operating Officer Michael Chi reported acquiring 365,058 shares of Class A common stock through earned performance-based restricted stock units (PRSUs). These PRSUs were previously granted and each unit represents the right to receive one share.

The Compensation Committee certified that the award's performance criteria were met as of February 23, 2026, and the shares are scheduled to be delivered to Chi on or about March 15, 2026. Following this grant, his direct holdings total 670,219 shares of Class A common stock.

Insider Trade Summary

Grant/Award: 365,058 shares

Grant/Award 1 txn

Insider Chi Michael

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	365,058	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 670,219 shares (Direct)

Footnotes (1)

1. F1. Represents performance-based restricted stock units (PRSUs) earned pursuant to a previously granted award. Each PRSU represents a contingent right to receive one share of the Company's Class A common stock. The Compensation Committee of the Company's Board of Directors certified that the performance criteria established in connection with this award has been met as of February 23, 2026. In accordance with the award's terms, the shares underlying the PRSUs will be delivered to the Reporting Person on or about March 15, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Hims & Hers Health (HIMS) report for Michael Chi?

Hims & Hers Health reported that COO Michael Chi acquired 365,058 shares of Class A common stock via earned performance-based restricted stock units. These units were previously granted and converted into shares after the company certified that performance goals had been met.

How many Hims & Hers (HIMS) shares does Michael Chi hold after this Form 4?

After this transaction, Michael Chi directly holds 670,219 shares of Hims & Hers Class A common stock. This total reflects the addition of 365,058 shares delivered from performance-based restricted stock units that were earned once specified performance criteria were certified as achieved.

What are the terms of Michael Chi’s performance-based RSUs at Hims & Hers?

Michael Chi’s award consists of performance-based restricted stock units where each PRSU equals one Class A share. The Compensation Committee certified on February 23, 2026 that the performance criteria were met, and the underlying 365,058 shares will be delivered on or about March 15, 2026.

Did Michael Chi buy Hims & Hers (HIMS) shares on the open market?

No, Michael Chi did not buy shares on the open market. He acquired 365,058 shares of Class A common stock at no price per share, as they were delivered from previously granted performance-based restricted stock units that vested after the company confirmed performance achievement.

When will Michael Chi receive the earned Hims & Hers PRSU shares?

The 365,058 shares underlying Michael Chi’s earned performance-based restricted stock units are scheduled to be delivered on or about March 15, 2026. This follows the Compensation Committee’s February 23, 2026 certification that the performance conditions for the award had been satisfied.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chi Michael

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/23/2026		A		365,058(1)	A	$0	670,219	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents performance-based restricted stock units (PRSUs) earned pursuant to a previously granted award. Each PRSU represents a contingent right to receive one share of the Company's Class A common stock. The Compensation Committee of the Company's Board of Directors certified that the performance criteria established in connection with this award has been met as of February 23, 2026. In accordance with the award's terms, the shares underlying the PRSUs will be delivered to the Reporting Person on or about March 15, 2026.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Michael Chi	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.